Detalles de la búsqueda
1.
The Future of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Disease.
Gastroenterology
; 162(5): 1525-1542, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34995532
2.
Towards excellence in cardiac surgery: experience from a developing country.
Int J Qual Health Care
; 27(4): 255-9, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26060228
3.
The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients.
EBioMedicine
; 88: 104430, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36634565
4.
Antibody responses to Influenza vaccination are diminished in patients with inflammatory bowel disease on infliximab or tofacitinib.
J Crohns Colitis
; 2023 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37941436
5.
Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study.
EClinicalMedicine
; 64: 102249, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37842172
6.
Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients: insights from a multicentre UK cohort study.
BMJ Open Gastroenterol
; 9(1)2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35101886
7.
Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study.
Aliment Pharmacol Ther
; 56(10): 1460-1474, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36196569
8.
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study.
Lancet Gastroenterol Hepatol
; 7(4): 342-352, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35123676
9.
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.
Nat Commun
; 13(1): 1379, 2022 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35296643
10.
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study.
Lancet Gastroenterol Hepatol
; 7(11): 1005-1015, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36088954
11.
Tacrolimus therapy in moderate to subacute ulcerative proctocolitis: a large single-centre cohort study.
Frontline Gastroenterol
; 9(2): 148-153, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29588844
12.
Editorial: the impact of COVID on the management of IBD flares: different care but similar outcomes-authors' reply.
Aliment Pharmacol Ther
; 57(1): 156-157, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36468219
13.
"Chase CRP", "Review patient": Improving the Quality of Weekend Medical Handover at a London Teaching Hospital.
BMJ Qual Improv Rep
; 4(1)2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26732516
14.
Improving the management of patients with acute red eyes in a large London Emergency Department.
BMJ Qual Improv Rep
; 3(1)2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-26734281
15.
Limitations of poster presentations reporting educational innovations at a major international medical education conference.
Med Educ Online
; 18: 1-4, 2013 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-24199272
Resultados
1 -
15
de 15
1
Próxima >
>>